查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1951245

細胞分離技術市場－全球產業規模、佔有率、趨勢、機會及預測（依產品、技術、應用、最終用途、地區及競爭格局分類），2021-2031年

Cell Separation Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technology, By Application, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球細胞分離技術市場預計將從 2025 年的 159.5 億美元成長到 2031 年的 270.6 億美元，複合年成長率為 9.21%。

這些技術，包括用於從血液和組織等多種生物來源中提取和純化特定細胞群的專用解決方案，在研究、診斷和治療應用中發揮著至關重要的作用。該領域的成長主要得益於再生醫學的快速發展以及對細胞療法（尤其是在腫瘤學和免疫學領域）日益成長的需求。生物技術研發投入的不斷增加進一步強化了這一趨勢，因為這些投入需要精確的細胞分離以進行下游分析和生產。正如再生醫學聯盟所指出的，預計到2024年，美國和歐洲將對多達17種新型細胞和基因療法做出監管決定，凸顯了強大的研發管線，並將推動對分離工具的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 159.5億美元
市場規模：2031年 270.6億美元
複合年成長率：2026-2031年 9.21%
成長最快的細分市場 腫瘤學研究
最大的市場 北美洲

儘管取得了這些進展，但先進分離設備的高成本和技術複雜性仍然是市場面臨的重大障礙。如何在不犧牲產量的前提下實現高純度和高活性仍然是一個挑戰，而自動化臨床級系統所需的大量資金有效地阻礙了小規模實驗室和新興生物技術公司採用這些系統。這種經濟壁壘限制了最尖端科技的普及，並可能阻礙市場更廣泛的擴張。

市場促進因素

細胞和基因治療領域的快速發展是推動先進細胞分離技術廣泛應用的主要動力。隨著自體和異體療法生產的擴大，分離高純度免疫細胞（例如T細胞和NK細胞）對於確保治療的安全性和有效性至關重要。活躍的臨床研發管線直接導致了磁珠以微珠為基礎系統和流式細胞技術平台採購量的增加，這些設備用於處理大量的生物材料。根據美國基因與細胞治療學會（ASGCT）2024年4月發表的《基因、細胞與RNA療法現況：2024年第一季季報告》，全球在開發平臺治療方法3951種，凸顯了該產業目前所需的龐大處理規模。

同時，慢性疾病（尤其是癌症）的日益流行，對用於基礎研究和診斷的可靠細胞分離通訊協定提出了更高的要求。在腫瘤學研究中，循環性腫瘤細胞和特定淋巴細胞亞群的分離對於了解疾病進展和開發精準治療方法至關重要，這推動了微流體技術和密度梯度離心技術在高度特異性樣本處理中的應用。美國癌症協會在2024年1月發布的報告《2024年癌症事實與數據》中預測，美國將新增2,001,140例癌症病例，凸顯了提高診斷通量的迫切需求。這項需求正得到業界的大力支持。根據歐洲製藥工業協會聯合會（EFPIA）2024年6月發布的報告《2024年製藥業數據》，以研發為導向的生物製藥行業預計將在2023年於歐洲投資500億歐元用於研發，從而確保關鍵分離基礎設施的持續資金籌措。

市場挑戰

全球細胞分離技術市場受到高額資本投入和先進分離設備技術複雜性的顯著限制。自動化臨床級系統的高昂價格為資源有限的機構（例如小規模實驗室和新興生物技術公司）設置了很高的進入門檻。這些機構往往難以證明高效能平台的初始投入是合理的，這限制了它們達到競爭性研發所需的純度和活力標準的能力。因此，這種經濟上的排他性阻礙了行業標準解決方案的廣泛應用，迫使小規模的企業依賴效率較低的手動方法。

早期企業的資金籌措環境日益惡化，進一步加劇了這種經濟壓力，直接導致資本設備預算縮減。根據生技創新組織（BIO）的數據顯示，生技Start-Ups的資金籌措從2025年第一季的26億美元驟降至第二季的僅9億美元。可用資金的急劇下降迫使新興企業推遲關鍵基礎設施升級，甚至完全放棄先進設備。因此，關鍵成長領域的市場採用率放緩，有效限制了整個細胞分離產業的擴張。

市場趨勢

一項重大的行業變革趨勢正在推動對單細胞分離解決方案的需求，其驅動力源於基因組學和太空生物學中分析細胞異質性的關鍵需求。研究人員越來越重視能夠溫和分離單一細胞並維持其高活性的技術，以確保下游應用（例如單細胞RNA定序和多體學分析）的完整性。這種轉變正將市場關注點從批量細胞分選轉向能夠無損處理脆弱樣本（例如分散的組織和罕見的患者樣本）的精準平台。 10x Genomics在2025年11月發布的2025年第三季財報中公佈了1.49億美元的營收，這印證了市場對高解析度工具的持續需求。這反映了該公司單細胞和空間分析架構的持續強勁應用，而該架構依賴高品質的上游工程細胞製備。

同時，市場正積極向全自動閉合迴路加工流程轉型，以支持細胞和基因療法的商業性規模生產。隨著治療方法從臨床開發推進到上市核准，製造商正從人工開放式分離方法轉向自動化平台，以確保符合良好生產規範 (GMP) 並最大限度地降低污染風險。這項轉變的驅動力在於商業規模生產中對產品品質一致性和可重複性的需求，這與早期研究階段的要求截然不同。法規核准的加速成功標誌著該行業的成熟。再生醫學聯盟在 2025 年 1 月發布的《2025 年產業趨勢簡報》中指出，2024 年新增細胞和基因療法核准數量創下歷史新高，達到 9 項，預示著該產業正向大規模、標準化的生產基礎設施發生重大轉變。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球細胞分離技術市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品分類（消耗品、設備）
    • 透過技術（表面標誌物分離、梯度離心）
    • 依應用領域（腫瘤學研究、幹細胞研究、神經科學研究、微生物學研究、免疫學研究等）
    • 依最終用戶（生物技術/生物製藥公司、細胞庫、學術機構）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美細胞分離技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲細胞分離技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區細胞分離技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲細胞分離技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美細胞分離技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球細胞分離技術市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Akadeum Life Sciences, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bristol-Myers Squibb Company
  • Danaher Corporation
  • GE HealthCare Technologies Inc.
  • Merck & Co., Inc.
  • STEMCELL Technologies Canada Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27658

The Global Cell Separation Technologies Market is projected to expand from USD 15.95 Billion in 2025 to USD 27.06 Billion by 2031, registering a compound annual growth rate of 9.21%. These technologies encompass specialized solutions designed to extract and purify distinct cell populations from heterogeneous biological sources, such as blood and tissue, serving critical roles in research, diagnostics, and therapeutic applications. The sector's momentum is primarily fueled by the burgeoning field of regenerative medicine and the escalating demand for cell-based therapies, especially within oncology and immunology. This trajectory is reinforced by growing investments in biotechnology research and development, which require precise cell isolation for downstream analysis and manufacturing. As noted by the Alliance for Regenerative Medicine, the industry anticipated up to 17 regulatory decisions for new cell and gene therapies in the United States and Europe during 2024, highlighting the robust pipeline stimulating the demand for separation tools.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 15.95 Billion
Market Size 2031USD 27.06 Billion
CAGR 2026-20319.21%
Fastest Growing SegmentOncology Research
Largest MarketNorth America

Despite these advancements, the market encounters significant hurdles related to the high costs and technical intricacies of advanced separation instruments. Balancing high purity and viability without sacrificing yield remains a persistent difficulty, while the substantial capital required for automated, clinical-grade systems can effectively bar adoption by smaller research laboratories and emerging biotechnology companies. This financial barrier limits the accessibility of cutting-edge technology, potentially impeding the broader expansion of the market.

Market Driver

The rapid proliferation of the cell and gene therapy sector serves as a major catalyst for the uptake of sophisticated cell separation technologies. As manufacturers ramp up production for autologous and allogeneic therapies, achieving high-purity isolation of immune cells, such as T-cells and NK cells, is essential for ensuring therapeutic safety and efficacy. This intense activity in clinical pipelines leads directly to increased procurement of magnetic bead-based systems and flow cytometry platforms to handle the volume of biological starting materials. According to the American Society of Gene & Cell Therapy's April 2024 report, "Gene, Cell, & RNA Therapy Landscape: Q1 2024 Quarterly Report," the global development pipeline has reached 3,951 therapies, emphasizing the massive processing scale currently required by the industry.

Simultaneously, the rising prevalence of chronic diseases, especially cancer, demands robust cell separation protocols for both fundamental research and diagnostic purposes. Oncological studies depend heavily on isolating circulating tumor cells and specific lymphocyte subsets to elucidate disease progression and create precision treatments, driving the use of microfluidics and density gradient centrifugation for high-specificity sample processing. The American Cancer Society projected in January 2024, within "Cancer Facts & Figures 2024," that the United States would see 2,001,140 new cancer cases, signaling an urgent need for higher diagnostic throughput. This demand is supported by significant industry commitment; as per the European Federation of Pharmaceutical Industries and Associations' June 2024 report, "The Pharmaceutical Industry in Figures 2024," the research-based biopharmaceutical industry invested €50 billion in R&D across Europe in 2023, securing continuous funding for vital separation infrastructure.

Market Challenge

The Global Cell Separation Technologies Market is significantly constrained by the substantial capital investment and technical sophistication associated with advanced separation instruments. Automated, clinical-grade systems come with premium pricing that creates a high barrier to entry for resource-limited entities, such as smaller research laboratories and nascent biotechnology firms. These organizations often find it difficult to justify the upfront costs of high-performance platforms, which limits their ability to attain the purity and viability standards necessary for competitive research and development. Consequently, this financial exclusivity hinders the widespread adoption of industry-standard solutions, compelling smaller players to depend on less efficient manual methods.

This economic pressure is intensified by a tightening funding landscape for early-stage companies, which directly curtails budgets for capital equipment. According to the Biotechnology Innovation Organization, biotech startup funding plummeted from $2.6 billion in the first quarter of 2025 to just $900 million in the second quarter. This sharp reduction in available capital forces emerging firms to postpone critical infrastructure upgrades or forego advanced instrumentation entirely. As a consequence, the market suffers from slower penetration rates in key growth segments, effectively restricting the overall expansion of the cell separation industry.

Market Trends

A major trend transforming the industry is the escalating demand for single-cell isolation solutions, spurred by the critical requirement to analyze cellular heterogeneity within genomics and spatial biology. Researchers are increasingly prioritizing technologies capable of gently isolating individual cells with high viability to preserve the integrity of downstream applications such as single-cell RNA sequencing and multi-omic profiling. This shift redirects market focus from bulk population sorting toward precision platforms that can process fragile inputs, like dissociated tissue or rare patient samples, without causing stress. Underscoring this sustained demand for high-resolution tools, 10x Genomics reported revenue of $149.0 million in its November 2025 "Third Quarter 2025 Financial Results," reflecting the continued robust adoption of its single-cell and spatial architectures that depend on high-quality upstream cell preparation.

Concurrently, the market is aggressively shifting toward fully automated and closed-loop processing workflows to support the commercial scale-up of cell and gene therapies. As therapies advance from clinical development to market authorization, manufacturers are substituting manual, open-system isolation methods with automated platforms that ensure Good Manufacturing Practice (GMP) compliance and minimize contamination risks. This evolution is driven by the need for consistent, reproducible product quality at a commercial scale, differing significantly from early-stage research requirements. The maturation of the industry is highlighted by accelerating regulatory success; the Alliance for Regenerative Medicine noted in its January 2025 "2025 State of the Industry Briefing" that the sector achieved a record nine new cell and gene therapy approvals in 2024, signaling a crucial pivot toward high-volume, standardized manufacturing infrastructure.

Key Market Players

  • Akadeum Life Sciences, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bristol-Myers Squibb Company
  • Danaher Corporation
  • GE HealthCare Technologies Inc.
  • Merck & Co., Inc.
  • STEMCELL Technologies Canada Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.

Report Scope

In this report, the Global Cell Separation Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Separation Technologies Market, By Product

  • Consumables
  • Instruments

Cell Separation Technologies Market, By Technology

  • Surface Markers Separation
  • Gradient Centrifugation

Cell Separation Technologies Market, By Application

  • Oncology Research
  • Stem Cell Research
  • Neuroscience Research
  • Microbiology
  • Immunology Research
  • Others

Cell Separation Technologies Market, By End Use

  • Biotechnology & Biopharmaceutical Companies
  • Cell Banks
  • Academic Institutes

Cell Separation Technologies Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Separation Technologies Market.

Available Customizations:

Global Cell Separation Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Separation Technologies Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables, Instruments)
    • 5.2.2. By Technology (Surface Markers Separation, Gradient Centrifugation)
    • 5.2.3. By Application (Oncology Research, Stem Cell Research, Neuroscience Research, Microbiology, Immunology Research, Others)
    • 5.2.4. By End Use (Biotechnology & Biopharmaceutical Companies, Cell Banks, Academic Institutes)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Cell Separation Technologies Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By End Use
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cell Separation Technologies Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End Use
    • 6.3.2. Canada Cell Separation Technologies Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End Use
    • 6.3.3. Mexico Cell Separation Technologies Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End Use

7. Europe Cell Separation Technologies Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By End Use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cell Separation Technologies Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End Use
    • 7.3.2. France Cell Separation Technologies Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End Use
    • 7.3.3. United Kingdom Cell Separation Technologies Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End Use
    • 7.3.4. Italy Cell Separation Technologies Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End Use
    • 7.3.5. Spain Cell Separation Technologies Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End Use

8. Asia Pacific Cell Separation Technologies Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By End Use
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cell Separation Technologies Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End Use
    • 8.3.2. India Cell Separation Technologies Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End Use
    • 8.3.3. Japan Cell Separation Technologies Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End Use
    • 8.3.4. South Korea Cell Separation Technologies Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End Use
    • 8.3.5. Australia Cell Separation Technologies Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End Use

9. Middle East & Africa Cell Separation Technologies Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By End Use
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cell Separation Technologies Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End Use
    • 9.3.2. UAE Cell Separation Technologies Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End Use
    • 9.3.3. South Africa Cell Separation Technologies Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End Use

10. South America Cell Separation Technologies Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technology
    • 10.2.3. By Application
    • 10.2.4. By End Use
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cell Separation Technologies Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End Use
    • 10.3.2. Colombia Cell Separation Technologies Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End Use
    • 10.3.3. Argentina Cell Separation Technologies Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cell Separation Technologies Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Akadeum Life Sciences, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Becton, Dickinson and Company
  • 15.3. Bio-Rad Laboratories, Inc.
  • 15.4. Bristol-Myers Squibb Company
  • 15.5. Danaher Corporation
  • 15.6. GE HealthCare Technologies Inc.
  • 15.7. Merck & Co., Inc.
  • 15.8. STEMCELL Technologies Canada Inc.
  • 15.9. Terumo Corporation
  • 15.10. Thermo Fisher Scientific Inc.

16. Strategic Recommendations

17. About Us & Disclaimer